← Back to Search

Intervention for Stomach Cancer

Phase 4
Waitlist Available
Led By Enrique F Elli, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 30-90 days after surgery
Awards & highlights

Study Summary

This trial will be testing the safety and effectiveness of the Indocyanine green dye (ICG) during surgery.

Eligible Conditions
  • Stomach Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 30-90 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 30-90 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disease positive lymph nodes
Number of lymph nodes removed for each lymphatic station of gastrectomy
Positive ICG fluorescence lymph nodes

Side effects data

From 2015 Phase 2 trial • 30 Patients • NCT01662752
97%
Wound pain
40%
Nausea
13%
Ileus
10%
Vomiting
7%
Bloating
7%
Urinary tract infection
3%
Atrial fibrillation
3%
Dizziness
3%
Palpitations
3%
Paroxysmal atrial fibrillation
3%
Constipations
3%
Distended abdomen
3%
Epigastric pain
3%
Hiccough
3%
Febrile reaction
3%
Rigors
3%
Postoperative ileus
3%
Low haemoglobin
3%
Groin pain
3%
Tremor
3%
Confusion
3%
Urinary retention
3%
Atelectasis
3%
Low blood pressure
100%
80%
60%
40%
20%
0%
Study treatment Arm
Indocyanine Green

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Injection of Indocyamine Green.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Indocyanine green
2016
Completed Phase 4
~1720

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,176 Previous Clinical Trials
3,758,311 Total Patients Enrolled
Enrique F Elli, MDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I fit the eligibility criteria to take part in this research?

"This clinical trial has a strict age limit of 18-75 and is only for patients with stomach cancer. They are looking to enroll 50 participants in total."

Answered by AI

Could you please provide an overview of the risks associated with this treatment?

"The safety of this treatment was given a score of 3. This is due to the fact that this Phase 4 trial means that this treatment is already approved."

Answered by AI

Can geriatric patients participate in this research?

"This trial is only for patients aged 18-75. If you are younger or older, there are 22 and 673 other trials you might be eligible for, respectively."

Answered by AI

How may patients will be given this experimental medication?

"Right now, this clinical trial has no open positions. The trial was first posted on 1/1/2023 and was last updated on 2/15/2022. However, there are 648 other trials for cancer of the stomach that are actively recruiting patients and 32 for this particular treatment."

Answered by AI
~0 spots leftby Mar 2025